Drug Design -- United States -- Congresses : Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary / Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, Rapporteurs ; Forum on Drug Discovery, Development, and Translation ; Board on Health Sciences Policy, Institute of Medicine of the National Academies
The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include pharmacokinetics, dosage analysis, or drug administration analysis
1
Drug detection. : La Familia Drug Cartel: Implications for U.S.-Mexican Security
Reduction of pharmacologic activity or toxicity of a drug or other foreign substance by a living system, usually by enzymatic action. It includes those metabolic transformations that make the substance more soluble for faster renal excretion
Drug development -- Africa : Drug discovery in Africa : impacts of genomics, natural products, traditional medicines, insights into medicinal chemistry, and technology platforms in pursuit of new drugs / Kelly Chibale, Mike Davies-Coleman, Collen Masimirembwa, editors
2012
1
Drug development -- Canada : Patently innovative : how pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs / Ron A. Bouchard
Drug development -- Economic aspects -- Congresses : Financial incentives to encourage development of therapies that address unmet medical needs for nervous system disorders : workshop summary / Sheena M. Posey Norris, Evelyn Strauss, Christopher DeFeo, and Clare Stroud, rapporteurs ; Forum on Neuroscience and Nervous System Disorders, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Drug development -- France : Navelbine® and Taxotère® : histories of sciences / Muriel Le Roux, Françoise Guéritte
2017
1
Drug development -- Government policy : Challenges to tackling antimicrobial resistance : economic and policy responses / edited by Michael Anderson, Michele Cecchini, Elias Mossialos
2020
1
Drug development -- Greece -- History -- To 1500 : Hippocratic recipes : oral and written transmission of pharmacological knowledge in fifth- and fourth-century Greece / by Laurence M.V. Totelin
Drug development -- India : Drug discovery and drug development : the Indian narrative / Madhu Dikshit, editor
2021
1
Drug Development -- instrumentation : Organ-on-a-chip : engineered microenvironments for safety and efficacy testing / edited by Julia Hoeng, David Bovard, Manuel Peitsch
Drug development -- Law and legislation -- United States -- Congresses : Enabling discovery, development, and translation of treatments for cognitive dysfunction in depression : workshop summary / Lisa Bain and Clare Stroud, rapporteurs ; Forum on Neuroscience and Nervous System Disorders, Board on Health Sciences Policy, Institute of Medicine, the National Academies of Sciences, Engineering, and Medicine
Drug development -- Mathematical models : Computational methods in drug discovery and repurposing for cancer therapy / edited by Ganji Purnachandra Nagaraju, Venkatesan Amouda, Ampasala Dinakara Rao
Drug Development -- methods : In silico drug design : repurposing techniques and methodologies / edited by Kunal Roy
2019
1
Drug development -- Moral and ethical aspects : Ethical innovation for global health : pandemic, democracy and ethics in research / Chieko Kurihara, Dirceu Greco, Ames Dhai, editors
